Sign Up to like & get recommendations! 1
Published in 2018 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2018.1176
Abstract: Importance Atrial fibrillation is a potent risk factor for stroke, but whether the burden of atrial fibrillation in patients with paroxysmal atrial fibrillation independently influences the risk of thromboembolism remains controversial. Objective To determine if… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2018.3945
Abstract: Importance Black and Hispanic patients are less likely than white patients to use oral anticoagulants for atrial fibrillation. Little is known about racial/ethnic differences in use of direct-acting oral anticoagulants (DOACs) for atrial fibrillation. Objective… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2022.3704
Abstract: Importance Oral anticoagulation (OAC) is underprescribed in underrepresented racial and ethnic group individuals with atrial fibrillation (AF). Little is known of how differential OAC prescribing relates to inequities in AF outcomes. Objective To compare OAC… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2022.4712
Abstract: This case report describes a patient in their 60s with a history of palpitations for more than 10 years and dyspnea for 3 years who had undergone a single-chamber pacemaker implant 10 years prior for… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.14321
Abstract: Key Points Question Does a single educational mailing to a patient with atrial fibrillation and their clinician increase the use of oral anticoagulants for stroke prevention? Findings This randomized clinical trial found no statistically significant… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "JAMA Neurology"
DOI: 10.1001/jamaneurol.2022.4038
Abstract: This prespecified analysis of the Stroke of Known Cause and Underlying Atrial Fibrillation (STROKE AF) randomized clinical trial investigates the association of commonly assessed risk factors with undiagnosed atrial fibrillation in patients with ischemic stroke… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Clinical Cardiology"
DOI: 10.1002/clc.22649
Abstract: Little is known about the comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulants (NOAC) compared to warfarin in Chinese atrial fibrillation (AF) patients. Our aim was to compare the ischemic stroke risk reduction… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Clinical Cardiology"
DOI: 10.1002/clc.22864
Abstract: The association between dyslipidemia, a major risk factor for cardiovascular diseases, and atrial fibrillation (AF) is not clear because of limited evidence. read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Clinical Cardiology"
DOI: 10.1002/clc.22971
Abstract: Guidelines recommend that patients with atrial fibrillation (AF) are involved in oral anticoagulant (OAC) treatment decisions. Understanding which OAC attributes AF patients value most could help optimize treatment. read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Clinical Cardiology"
DOI: 10.1002/clc.23051
Abstract: Most antiarrhythmic interventional therapies for atrial fibrillation (AF) have been provided with special focus on the treatment of left‐sided valvular disease and enlarged left atrium but few studies have assessed AF associated with congenital heart… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Clinical Cardiology"
DOI: 10.1002/clc.23147
Abstract: Despite progresses in the treatment of the thromboembolic risk related to atrial fibrillation (AF), the management of recurrences remains a challenge. read more here.